Post Holdings' (POST) third-quarter fiscal 2020 results reflect lower sales. Weakness in the Foodservice and BellRing Brands businesses hurt the performance.
Medifast Inc (NYSE:MED) traded in a range yesterday that spanned from a low of $159.20 to a high of $177.70. Yesterday, the shares fell 11.4%, which took the trading range below the 3-day low of $165.00...
Medifast's (MED) second-quarter 2020 results reflect solid earnings and sales. Strong OPTAVIA performance, thanks to a substantial rise in active earning coaches, boosted results.
Medifast (MED) delivered earnings and revenue surprises of 6.52% and 12.97%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
BALTIMORE (AP) _ Medifast Inc. (MED) on Wednesday reported second-quarter profit of $21.9 million.
, /PRNewswire/ -- Medifast (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, VIA®, today reported results for the second quarter ended .
Adverse impacts of coronavirus-induced temporary retail outlet closures are likely to get reflected in Inter Parfums' (IPAR) second-quarter 2020 performance.
Zacks.com featured highlights include: Medifast, USANA Health, UFP Industries, AllianceBernstein and Landstar System
Seven top-ranked companies are poised to beat on earnings today after the closing bell.
Strength in branded retail with Nature's Own, Canyon Bakehouse, Dave's Killer Bread and Wonder brands might reflect on Flowers Foods' (FLO) Q2 results.
TreeHouse Foods' (THS) second-quarter 2020 results are expected to reflect gains from increased demand and greater at-home consumption, offset by high costs and a soft Food Away From Home business.
Bet on six top-ranked stocks with higher ROE derived the DuPont way.
The Zacks Analyst Blog Highlights: Reynolds Consumer Products, Ollie's Bargain Outlet, Medifast and Flowers Foods
Strength in OPTAVIA brand is likely to get reflected in Medifast's (MED) second-quarter 2020 performance. However, rising SG&A expenses is a concern.
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
The gradual easing of restrictions followed by the opening of the economy will boost spending which had hit rock bottom over the past few of months.
The Zacks Analyst Blog Highlights: BGS, MNST, MED, NUS and FLO
Beyond Meat's (BYND) second-quarter results are likely to reflect strength in the retail business due to higher at-home consumption, while the foodservice business may remain under pressure.
Monster Beverage's (MNST) energy drink category is likely to have favorably impacted the company's second-quarter earnings results.
The consumer staples sector has so far reported relatively better results despite the decline of overall sector's earnings year over year.